Aziyo biologics appoints peter g. edwards as general counsel

Silver spring, md., aug. 31, 2021 (globe newswire) -- aziyo biologics, inc. (nasdaq: azyo), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced the appointment of peter g. edwards as general counsel.
AZYO Ratings Summary
AZYO Quant Ranking